Navigation Links
New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes
Date:6/8/2008

argine cohorts have similar demographic and clinical profiles. Primary outcomes included DACON of insulin detemir or insulin glargine, A1C levels following initiation of insulin therapy, and overall and diabetes-related cost.

Following the six-month analysis period, adjusted DACON for basal only insulin detemir and insulin glargine cohorts were 29.3 and 29.6 units/day respectively (p=0.93). No significant difference in diabetes-related pharmacy cost was observed ($1,277 vs. $1,149; p=0.23).

About Levemir(R) (insulin detemir [rDNA origin] injection)

Levemir(R) (insulin detemir [rDNA origin] injection) is a long-acting insulin analog indicated for once- or twice-daily subcutaneous administration for the treatment of adults and children with type 1 diabetes mellitus and adult patients with type 2 diabetes mellitus who require basal (long-acting) insulin for the control of hyperglycemia. Levemir(R) has a relatively flat action profile with up to 24 hours duration of action. It can be added to oral anti-diabetic agents, or used in combination with a rapid-acting insulin. Levemir(R) is available in FlexPen(R), a prefilled disposable insulin pen for easy, discreet dosing and in vials.

Levemir(R) was approved by the U.S. Food and Drug Administration in June 2005 and was launched in the U.S. in March 2006. Levemir(R) has been available for use in Europe since March 2004 and is currently approved in 50 countries worldwide. Levemir(R) is contraindicated in patients hypersensitive to insulin detemir or its excipients. Hypoglycemia is the most common adverse effect of all insulin therapies, including Levemir(R). As with all insulins, the timing of hypoglycemic events may differ among various insulin formulations. Glucose monitoring is recommended for all patients with diabetes. Other adverse events commonly associated with insulin therapy may include injection site reactions (on average 3-4 percent of patients in clinical trials) such as lipodystrophy
'/>"/>

SOURCE Novo Nordisk
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cleveland Clinic to Lead First Head-to-Head Comparison of the Two Most Potent Statins
2. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
3. New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study
4. Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
5. Study Shows Lantus(R) Helped People Living with Type 2 Diabetes Reach the ADAs Recommended Target for Blood Sugar Control
6. The Largest Ever Study of Diabetes Shows Intensive Glucose Control Reduces Serious Complications
7. Leading Academic Institutions Collaborate on 800-Patient Study of Effectiveness of Cryoablation for Men With Recurrent Prostate Cancer
8. Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients
9. Semafore Pharmaceuticals Reports Positive Interim Results from a Phase I Study of SF1126, a Targeted Pan-PI3K Inhibitor, in Patients with Advanced Solid Tumors
10. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
11. Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Inivata, a Cambridge, England -based ... the 2015 American Association for Cancer Research (AACR) Annual Meeting ... and a poster presentation. Michael Stocum , CEO ... nd . The presentation, entitled Monitoring the ... part of a session on Recent Advances in Diagnostics ...
(Date:4/17/2015)... and Markets ( http://www.researchandmarkets.com/research/lmsnqn/medical_equipment ) has announced ... Leasing - Global Strategic Business Report" report to ... markets for Medical Equipment Rental and Leasing in US$ ... US, Japan , Europe ... estimates and forecasts are provided for the period 2014 ...
(Date:4/17/2015)... 2015  Trovagene, Inc., (NASDAQ:  TROV) a developer ... data presented at the 2015 European Lung Cancer ... Monitoring ℠ (PCM) platform outperformed tissue biopsy ... T790M mutations in metastatic lung cancer patients. ... Mutation in Urinary Circulating Tumor DNA from Metastatic ...
Breaking Medicine Technology:Inivata Co-founder Nitzan Rosenfeld to Present at AACR Annual Meeting 2Medical Equipment Rental and Leasing Market 2015-2020 - Global Strategic Business Report - Healthcare Spending Slowdown Bodes Well for Medical Equipment Leasing 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4
... 18 Novavax, Inc. (Nasdaq: NVAX ) a ... , President and Chief Executive Officer, will be presenting at ... 21 and June 22, 2010 at The ... in the roundtable discussion, , Getting ready for the next ...
... , June 17 Allied Healthcare Products, Inc. (Nasdaq: ... carbon dioxide absorbent that provides enhanced patient safety over conventional absorbents ... , ... commonly associated with conventional carbon dioxide absorbents, yet it has been ...
Cached Medicine Technology:Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2010 2Allied Healthcare Announces Litholyme(TM) -- New CO2 Absorbent Used in Anesthesia 2
(Date:4/18/2015)... April 18, 2015 In the past ... couple of changes. , "We had to run maintenance ... needed changes," said Jennifer Ramirez, the PR Director. "It ... to say that we are back on track after ... the process of changing phone systems which has not ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 On April 14th, ... Threat Report , which they say, “exposes a tactical shift ... new malware variants were introduced in 2014 - almost a ... Zero Day threats to be identified and patched by prominent ... abundantly clear that doing business in a digital world can ...
(Date:4/18/2015)... 2015 “ ArcAngel ” was featured on ... look at the latest and coolest applications on ... host of AppWatch and technology expert, conducted the app review ... app. , In a turbulent world, people may find ... should always be their first move, but some situations can ...
(Date:4/18/2015)... French physician and gastronome Anthelme Brillat-Savarin ... he uttered, “Tell me what you eat, and I ... cope with stress or sadness has often been attributed ... otherwise. Data collected from their Emotional Eating Test ... eating, but for different reasons. , Collecting data from ...
(Date:4/17/2015)... John Evans, a Gardant affordable assisted ... from 2 p.m. to 3 p.m. on April 24. ... Ct. in Pekin, Illinois, serves older adults of all ... to maintain their independence. , Becky Baker will entertain ... be served during the luau. , For more information, ...
Breaking Medicine News(10 mins):Health News:TheBeautyPlace.com Temporary Number Available 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5Health News:A Personal Safety Application was Featured on NewsWatch Television 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6Health News:John Evans Supportive Living Community Prepares for Party on the Patio 2
... June 27, HIV Testing Day, the HIV Medicine Association (HIVMA) ... in linking people to lifesaving care and reducing the spread ... HIVMA calls on policymakers to do more to make every ... covers such screening as a standard part of routine medical ...
... 22 Epeius Biotechnologies ( www.epeiusbiotech.com ) ... demonstration of single-agent efficacy with its lead product, Rexin-G, ... of June 16, 2009 in Molecular Therapy, the Official ... www.nature.com/mt/ ) documents the results of two ...
... Lead Educational Underwriter , , WASHINGTON, June 22 ... Innovation and Technology Congress (WHIT 5.0), in conjunction with ... announces that President Bill Clinton will deliver a keynote ... 2009. , , President Clinton will join ...
... D.C., June 23, 2009 With millions of people in ... and our Canadian neighbors doing likewise for their July ... light shows of the future likely to ignite a smile ... fireworks is quietly making its way toward the sky. ...
... MapHIV.org Shows Vast Majority of Nation,s HIV Burden Clustered in ... The National Minority Quality Forum ... highlights the impact of the HIV/AIDS epidemic in communities across ... rates available in a single location for the first time, ...
... National Minority Quality Forum Launches First U.S. HIV/AIDS Atlas , ... Minority Quality Forum today launched a groundbreaking HIV/AIDS Atlas ( ... of the HIV/AIDS epidemic in communities across the United States. ... in a single location for the first time, painting a ...
Cached Medicine News:Health News:On HIV Testing Day, HIVMA calls for health care reform to make testing routine every day 2Health News:Clinical Studies Validate Cancer Gene Delivery Platform: Landmark Publication Confirms Rexin-G Effectively Targets Metastatic Cancers and Improves Patient Survival 2Health News:President Bill Clinton to Deliver Keynote Address at 5th Annual World Healthcare Innovation and Technology Congress, November 10, 2009, Washington, D.C. 2Health News:President Bill Clinton to Deliver Keynote Address at 5th Annual World Healthcare Innovation and Technology Congress, November 10, 2009, Washington, D.C. 3Health News:'Green' fireworks may brighten eco-friendly 4th of July displays in future 2Health News:Video: National Minority Quality Forum Launches First U.S. HIV/AIDS Atlas 2Health News:Video: National Minority Quality Forum Launches First U.S. HIV/AIDS Atlas 3Health News:MapHIV.org Shows Massachusetts' Suffolk County Seriously Impacted by HIV and AIDS 2Health News:MapHIV.org Shows Massachusetts' Suffolk County Seriously Impacted by HIV and AIDS 3
Enzyme Immunoassay for the quantitative ( qualitative 0020, on request) determination of IgG Class antibodies to Rubella virus....
Donor Screen & Confirmation Kit...
... antibody gives positive staining of prostatic ... hyperplasia. In cases of prostatic cancer, ... give definite but weak staining or ... cells; this pattern of staining permits ...
... a comprehensive line of pregnancy tests including ... in convenient one-step stick and cassette formats. ... Clearview Easy HCG is a 25 mIU ... Clearview HCG II provides 25mIU sensitivity ...
Medicine Products: